Leveraging Analytics to Ensure Stable & Scalable Cell Lines

At BioProcess International East, our Head of Cell Line Development, Dr. Brett Verstak, spoke about how our newly enhanced AbZelectPRO™ CHO-K1 & GS Knockout cell line development platforms leverage a comprehensive analytics portfolio to simplify the IND application process and deliver customer therapeutic proteins successfully to clinical phases in an accelerated timeframe.

Watch Brett’s presentation below and contact our cell line development experts today.

Presentation Overview

• Overview of Abzena
• Introduction to our AbZelectPRO™ CLD PLatform
• Target Product Profile (TPP)
• CLD Workflow with Supporting Analytics
• Abzena’s Enhanced CLD Expertise

Learn more here: Cell Line Development Services